PODCAST
On The Pen With Dave Knapp
Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
All Episodes
00:42:22
GLP-1 Microdosing For Weight Loss: Noom CEO Explains...
On The Pen With Dave Knapp
·
2025/08/13
en-us
00:59:23
Eli Lilly Earnings Call Recap: Stock Tanks on Weight...
On The Pen With Dave Knapp
·
2025/08/07
en-us
00:24:38
Novo Nordisk Blames Compound Semaglutide on Slower Sales
On The Pen With Dave Knapp
·
2025/08/07
en-us
00:41:14
00:26:46
LEAKED TRUMP DOCUMENT: Medicare to Cover Zepbound and...
On The Pen With Dave Knapp
·
2025/08/01
en-us
00:33:17
00:24:04
00:26:22
00:20:20
SHOCKING: How GLP-1 Protects the Heart Beyond Weight...
On The Pen With Dave Knapp
·
2025/07/15
en-us
00:17:34
00:35:23
00:33:37
00:26:52
Lilly Could Lose Their Tirzepatide Patent! Plus ADA...
On The Pen With Dave Knapp
·
2025/06/24
en-us
00:57:43
00:29:32
00:22:33
00:21:18
00:29:47
00:41:02
00:26:31
Compound Tirzepatide Lawsuit + PBM Reform Update //...
On The Pen With Dave Knapp
·
2025/05/06
en-us